The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
Or, how $RVMD is now worth $30B
https://t.co/iFilUpezjn via @angRchen#AACR26
Beef tallow is healthier than seed oils? That’s what influencers and health secretary Robert F Kennedy Jr are saying but the experts, including @cityofhope dietician Adern Yu, refute this claim. https://t.co/Noi5uwW4VM
So sad. I’m not in my golden years yet but already feel settled and comfortable in my routines. To live with such uncertainty and build from scratch…build something you might not live to see…heartbreaking. https://t.co/fGwlRuMYlo
Board-certified oncologists and #MedTwitter: As you vote in the @usnews “Best Hospitals for Cancer” ranking, consider @cityofhope’s impact. We're committed to pursuing cures at the speed of life.
Learn more: https://t.co/ttsSOoYmfU
Dr. Jeffrey Wong @cityofhope et al developed regimen that possibly effective hematopoietic cell transplant option for AML/ALL pts w recurrent cancer or resistant disease. Regimen under evaluation as replacement for standard total body irradiation conditioning in AML pts. #ASTRO24
.@cityofhope was 1st in SoCal & amg 1st in US to adopt biology-guided radiotherapy called SCINTIX therapy that later in 2023 was cleared by @us_fda. Dr. Chunhui Han on his #ASTRO24 data that led to development of screening criteria to ID ppl who would benefit from treatment.
Discussant compares LU005 data presented by @cityofhope’s Dr. Kristin Higgins at #ASTRO24 to #ESMO24 ADRIATIC data, saying close interval b/t radiotherapy and immunotherapy start can maximize RT-induced immune activation while minimizing RT immune cytotoxicity.
.@cityofhope Dr. Kristin Higgins presenting #ASTRO24 LBA02. 👏 LU005 P3 data: Ppl w small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not at the same time. Results suggest timing of immunotherapy plays key role in its ability to extend survival.
.@cityofhope Dr. Kristin Higgins presenting #ASTRO24 LBA02. 👏 LU005 P3 data: Ppl w small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not at the same time. Results suggest timing of immunotherapy plays key role in its ability to extend survival.
.@cityofhope Dr. Yufei Liu is sharing a new way to determine the strength of phase 3 clinical trials at #ASTRO24. Evaluating 332 P3 trials, Dr. Liu and team found that trials that had progression-free survival as a primary endpoint were stronger than ones with overall survival.
Initial results of a phase 2 trial of stereotactic body radiation therapy, hormone/androgen deprivation therapy, and radium 223 dichloride for oligometastatic #CSPC#SHARP. Presented by Savita Dandapani @cityofhope. #ASTRO24 coverage by @chavarriagaj > https://t.co/G33f13emSs
@KHigginsMD, chief clinical officer at City of Hope Atlanta, invites you to visit City of Hope’s booth during the 2024 @ASTRO_org Annual Meeting.
Find us at Booth No. 2407 in the exhibition hall!
More details: https://t.co/IgkJSsaOZM @COH_RadOnc#ASTRO24
Excited to be at #ASTRO24 supporting @cityofhope’s leading-edge cancer research and treatment. At Dr. Savita Dandapani’s presentation on a promising treatment regimen for prostate cancer patients. Check it out and all of City of Hope’s ASTRO presence https://t.co/O5OkpUT4Xx
Proud to be working at a cancer center that continues to climb in the rankings. Eye on the prize…innovative, compassionate care for cancer patients and their family members 💙